November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Scott Thacher: State cancer agency awards $89 million in grants to Texas institutions and companies
Nov 25, 2024, 15:06

Scott Thacher: State cancer agency awards $89 million in grants to Texas institutions and companies

Scott Thacher, CEO and founder of Orphagen Pharmaceuticals, shared a post on LinkedIn:

“Texas calls.

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that it plans to award Orphagen a $10.2 M product development grant over three years to partially fund the final steps towards IND filing and a Phase 1 clinical trial of OR-449, a novel therapeutic candidate for an intractable cancer, adrenocortical cancer (ACC). OR-449 may be developed subsequently in head and neck and lung squamous cancers as a therapy for the 3-10% of these tumors where its target is highly expressed.”

Read more.

Read more about Orphagen.

For more updates, follow OncoDaily.